Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 ... - Bradenton Herald PDF Print
Bradenton Herald
... a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease (the "Company"), ...
Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.